Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates

Seres Therapeutics (MCRB) Reports In-Line Q1 EPS, Revenues Miss

May 7, 2020 7:57 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $8.19 million versus the consensus estimate of $8.53 million.

We were pleased to have recently achieved the important milestone of completing enrollment of our... More